Home > Clinical Trials
Check All Search

Saved trials

COMPLETED
NCT01717586
Pravastatin for Prevention of Preeclampsia
48 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE1)
Preeclampsia
RECRUITING
NCT06837792
Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer
141 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative)
RECRUITING
NCT06947707
Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
1,486 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Cerebral Venous Thrombosis


Anticoagulants and Thrombotic Disorders


Anticoagulation Treatment


Anticoagulant Therapy


Anticoagulant Drugs


NOACs


Anticoagulant Prophylaxis/Therapy


Anticoagulation With NOAC


Anticoagulation With Direct Oral Anticoagulants
COMPLETED
NCT05122455
Effects of Edoxaban on Platelet Aggregation
61 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2|||PHASE3)
SCAD


AMI
ACTIVE_NOT_RECRUITING
NCT06945224
A ReaL World Study of DS-8201
300 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Breast Cancer Metastatic


Treatment Efficacy
COMPLETED
NCT06930937
To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 mg Filmtabletten (Film Coated Tablet) (Edoxaban) in Healthy, Adult, Human Subjects Under Fasting Conditions
42 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
Prevention of Stroke or Systemic Embolism


Deep Vein Thrombosis (DVT)


Pulmonary Embolism (PE)
COMPLETED
NCT05524246
Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index
25 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Hematopoietic Stem Cell Transplant (HSCT)


Endothelial Injury
RECRUITING
NCT06821191
Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study
78 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Artery Disease